Mr. Rafael Begluyan is a Los Angeles, California based nurse practitioner who is specialized as Acute Care nurse. His current practice location is 1520 San Pablo St Ste 1000, Los Angeles. Patients can reach him at 323-442-5100. Mr. Rafael Begluyan is NP-C with specialization in Acute Care and his NPI number (Unique professional ID assigned by NPPES) is 1740701572. Mr. Rafael Begluyan is a licensed independent practitioner and may autonomously provide care. He provides advanced nursing care across the continuum of health care services to meet the specialized physiologic and psychological needs of patients with acute, critical, and/or complex chronic health conditions. This care is continuous and comprehensive and may be provided in any setting where the patient may be found.
Complete Profile:
Mr. Rafael Begluyan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Mr. Rafael Begluyan
Specialization:
Acute Care Nurse Practitioner (ACNP)
Gender:
Male
Credentials:
NP-C
Practice Address:
1520 San Pablo St Ste 1000, Los Angeles, California, 90033-5312
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1740701572
NPI Enumeration Date:
01 Jul, 2017
NPI Last Update On:
02 Jan, 2024
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mr. Rafael Begluyan Po Box 31309, Los Angeles, California
Zip:
90031-0309
Phone Number:
323-442-5100
Patients can reach Mr. Rafael Begluyan at 1520 San Pablo St Ste 1000, Los Angeles, California or can call to book an appointment on 323-442-5100.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.